Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02848885 : The Effects of tDCS on Illness Awareness in Schizophrenia
PhaseN/A
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

1. Male or female inpatients or outpatients = 18 years of age

2. Having a DSM-IV diagnosis of schizophrenia or schizoaffective disorder

3. Voluntary and capable of consenting to participation in the research study

4. Fluent in English

5. Moderate-to-severe lack of illness awareness (=3 on PANSS G12 Insight and Judgment
item)

6. On a stable dose of antipsychotic and other concomitant medications, and unlikely to
undergo changes in dose during the study

Exclusion Criteria:

1. Serious unstable medical illness or any concomitant major medical or neurological
illness, including a history of seizures or a first degree relative with a history of
a seizure disorder

2. Acute suicidal and/or homicidal ideation

3. Formal thought disorder rating of over 2 on the (Scale for Assessment of Positive
Symptoms) SAPS.

4. DSM-IV substance dependence (except caffeine and nicotine) within one month prior to
entering the study

5. Pregnant women

6. Mild lack of insight to good illness awareness (<3 on PANSS G12 Insight and Judgment
item).

7. Positive urine drug screen for drugs of abuse

8. Currently taking antiepileptics

9. Any contraindications to MRI (eg., metal implants that would preclude an MRI,
claustrophobia)

10. Score < 32 on the Wide Range Achievement Test-III (WRAT III)
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02848885      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740